Jiayi Yu

2.7k total citations
79 papers, 1.7k citations indexed

About

Jiayi Yu is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jiayi Yu has authored 79 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 28 papers in Molecular Biology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jiayi Yu's work include Melanoma and MAPK Pathways (11 papers), Cutaneous Melanoma Detection and Management (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Jiayi Yu is often cited by papers focused on Melanoma and MAPK Pathways (11 papers), Cutaneous Melanoma Detection and Management (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Jiayi Yu collaborates with scholars based in China, United States and Ethiopia. Jiayi Yu's co-authors include Shao‐Cong Sun, Xuhong Cheng, Yichuan Xiao, Xiaofei Zhou, Jae‐Hoon Chang, Mikyoung Chang, George C. Brittain, Hongbo Hu, Jin Jin and Junya Yan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jiayi Yu

72 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiayi Yu China 22 732 657 517 359 115 79 1.7k
Zhaoxia Qu United States 30 815 1.1× 797 1.2× 604 1.2× 456 1.3× 162 1.4× 60 2.0k
Michael A. Sheard United States 27 796 1.1× 741 1.1× 747 1.4× 298 0.8× 89 0.8× 51 2.1k
Rui Chen China 24 883 1.2× 901 1.4× 479 0.9× 609 1.7× 155 1.3× 88 2.2k
Rong Zhang China 27 280 0.4× 1.0k 1.5× 505 1.0× 382 1.1× 126 1.1× 109 2.0k
Lingyun Long United States 20 1.1k 1.5× 978 1.5× 611 1.2× 403 1.1× 286 2.5× 27 2.3k
Andreas Leibbrandt Austria 13 740 1.0× 981 1.5× 691 1.3× 315 0.9× 80 0.7× 19 2.1k
Zeyu Chen China 19 1.2k 1.6× 869 1.3× 875 1.7× 288 0.8× 128 1.1× 68 2.3k
Meng Zhao China 21 440 0.6× 730 1.1× 363 0.7× 359 1.0× 129 1.1× 65 1.7k
Ming Tang China 21 302 0.4× 965 1.5× 352 0.7× 318 0.9× 99 0.9× 63 1.8k
Soo Young Lee South Korea 21 729 1.0× 1.5k 2.3× 619 1.2× 464 1.3× 175 1.5× 36 2.5k

Countries citing papers authored by Jiayi Yu

Since Specialization
Citations

This map shows the geographic impact of Jiayi Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayi Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayi Yu more than expected).

Fields of papers citing papers by Jiayi Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayi Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayi Yu. The network helps show where Jiayi Yu may publish in the future.

Co-authorship network of co-authors of Jiayi Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayi Yu. A scholar is included among the top collaborators of Jiayi Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayi Yu. Jiayi Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Zhang, Xinyuan, Miao Guo, Jinlong Zhang, et al.. (2024). Comprehensive evaluation of the efficacy and safety of a new multi‐component anti‐aging topical eye cream. Skin Research and Technology. 30(7). e13790–e13790. 3 indexed citations
5.
Huang, Pan, Changbing Zheng, Jie Zheng, et al.. (2023). Development and Recovery of Liver Injury in Piglets by Incremental Injection of LPS. Antioxidants. 12(6). 1143–1143. 9 indexed citations
6.
Li, Qian, Xiaojiao Li, Dan Zhang, et al.. (2023). Development of a CT radiomics nomogram for preoperative prediction of Ki-67 index in pancreatic ductal adenocarcinoma: a two-center retrospective study. European Radiology. 34(5). 2934–2943. 15 indexed citations
7.
Wang, Yongjiang, Jiayi Yu, Jie Li, et al.. (2023). Genomic and structural basis for evolution of tropane alkaloid biosynthesis. Proceedings of the National Academy of Sciences. 120(17). e2302448120–e2302448120. 20 indexed citations
8.
Cui, Chuanliang, Xuan Wang, Bin Lian, et al.. (2022). OrienX010, an oncolytic virus, in patients with unresectable stage IIIC–IV melanoma: a phase Ib study. Journal for ImmunoTherapy of Cancer. 10(4). e004307–e004307. 38 indexed citations
9.
Tang, Zhuoyue, et al.. (2022). The application of 3-dimensional magnetic resonance imaging in nasopharyngeal carcinoma with pterygopalatine fossa invasion. Magnetic Resonance Imaging. 96. 38–43. 1 indexed citations
10.
Zhang, Dan, Xiaojiao Li, Liang Lv, et al.. (2020). <p>A Preliminary Study of CT Texture Analysis for Characterizing Epithelial Tumors of the Parotid Gland</p>. Cancer Management and Research. Volume 12. 2665–2674. 9 indexed citations
11.
Yan, Junya, Xiaowen Wu, Jiayi Yu, et al.. (2018). Establishment and characterization of melanoma patient-derived xenograft models for preclinical evaluation of novel therapeutics. Melanoma Research. 28(6). 527–535. 3 indexed citations
12.
Xu, Tianxiao, Meng Ma, Jie Dai, et al.. (2018). Gene expression screening identifies CDCA5 as a potential therapeutic target in acral melanoma. Human Pathology. 75. 137–145. 8 indexed citations
13.
Yan, Junya, Xiaowen Wu, Jiayi Yu, et al.. (2017). Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitor. European Journal of Cancer. 89. 90–101. 17 indexed citations
14.
Chi, Zhihong, Bixia Tang, Xinan Sheng, et al.. (2017). A phase I study of JS001, a humanized IgG4 mAb against programmed death-1 (PD-1) in patients with advanced solid tumors.. Journal of Clinical Oncology. 35(15_suppl). 3067–3067. 1 indexed citations
15.
Ma, Meng, Jie Dai, Tianxiao Xu, et al.. (2017). Analysis of TSC1 mutation spectrum in mucosal melanoma. Journal of Cancer Research and Clinical Oncology. 144(2). 257–267. 13 indexed citations
16.
Wu, Xiaowen, Junya Yan, Jie Dai, et al.. (2017). Mutations in BRAF codons 594 and 596 predict good prognosis in melanoma. Oncology Letters. 14(3). 3601–3605. 24 indexed citations
17.
Zhang, Xuesong, Wenhao Hu, Jiayi Yu, Zheng Wang, & Yan Wang. (2016). An Effective Treatment Option for Kümmell Disease With Neurological Deficits. Spine. 41(15). E923–E930. 40 indexed citations
18.
Nie, Ming, Jiayi Yu, Ming Xiao, et al.. (2011). Understanding Plant-Microbe Interactions for Phytoremediation of Petroleum-Polluted Soil. PLoS ONE. 6(3). e17961–e17961. 74 indexed citations
19.
Chang, Mikyoung, Wei Jin, Jae‐Hoon Chang, et al.. (2011). The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity. Nature Immunology. 12(10). 1002–1009. 147 indexed citations
20.
Zhang, Minying, Wei Jin, Xiaofei Zhou, et al.. (2008). Deregulation of Tpl2 and NF-κB signaling and induction of macrophage apoptosis by the anti-depressant drug lithium. Cellular Signalling. 21(4). 559–566. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026